Literature DB >> 2848327

Collagenase and fibronectin in bronchoalveolar lavage fluid in patients with sarcoidosis.

C O'Connor1, C Odlum, A Van Breda, C Power, M X Fitzgerald.   

Abstract

Bronchoalveolar lavage fluid from 43 patients with biopsy proved sarcoidosis and 10 control subjects were assayed for fibronectin and collagenase activity. Fibronectin was significantly increased in the group with sarcoidosis and was found to be positively correlated with angiotensin converting enzyme activity, protein concentration, percentage of T cells and helper:suppressor ratios in the lavage fluid. Increased fibronectin in the bronchoalveolar lavage fluid was not related to functional or radiographic indices of interstitial disease and did not identify patients subsequently requiring treatment. Latent collagenase was present in bronchoalveolar lavage fluid from 16 patients with sarcoidosis but not in any control sample. There was no association between the collagenase activity and the cell profiles of the lavage fluid. Yet carbon monoxide transfer factor was decreased in patients with bronchoalveolar lavage fluid collagenase. Ten of 16 patients with bronchoalveolar lavage fluid collagenase had radiographic class III or IV disease and a disease duration of more than two years. On follow up 62% of patients with bronchoalveolar lavage fluid collagenase required subsequent treatment, compared with only 23% of patients without collagenase. These results indicate an association between bronchoalveolar lavage fluid collagenase and progressive, prolonged disease in sarcoidosis, whereas increased bronchoalveolar lavage fluid fibronectin is associated with indices of disease activity.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2848327      PMCID: PMC461260          DOI: 10.1136/thx.43.5.393

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  26 in total

1.  Collagenase in the lower respiratory tract of patients with idiopathic pulmonary fibrosis.

Authors:  J E Gadek; J A Kelman; G Fells; S E Weinberger; A L Horwitz; H Y Reynolds; J D Fulmer; R G Crystal
Journal:  N Engl J Med       Date:  1979-10-04       Impact factor: 91.245

2.  A rapid sensitive collagenase assay.

Authors:  M T Gisslow; B C McBride
Journal:  Anal Biochem       Date:  1975-09       Impact factor: 3.365

3.  Determination of protein: a modification of the Lowry method that gives a linear photometric response.

Authors:  E F Hartree
Journal:  Anal Biochem       Date:  1972-08       Impact factor: 3.365

4.  An improved assay of mammalian collagenase activity, and its use to determine hepatic extracellular matrix susceptibility to degradation.

Authors:  W J Lindblad; G C Fuller
Journal:  Clin Chem       Date:  1982-10       Impact factor: 8.327

5.  A radiographic classification for sarcoidosis: physiologic correlation.

Authors:  T C McLoud; G R Epler; E A Gaensler; G W Burke; C B Carrington
Journal:  Invest Radiol       Date:  1982 Mar-Apr       Impact factor: 6.016

6.  Bronchoalveolar cells in advanced pulmonary sarcoidosis.

Authors:  C Roth; G J Huchon; A Arnoux; G Stanislas-Leguern; J H Marsac; J Chretien
Journal:  Am Rev Respir Dis       Date:  1981-07

7.  Pathogenesis of apneas in hypersomnia-sleep apnea syndrome.

Authors:  E Onal; M Lopata; T O'Connor
Journal:  Am Rev Respir Dis       Date:  1982-02

8.  Broncho-alveolar lavage in sarcoidosis. Correlation between alveolar lymphocytosis and clinical data.

Authors:  A Arnoux; J Marsac; G Stanislas-Leguern; G Huchon; J Chretien
Journal:  Pathol Res Pract       Date:  1982-10       Impact factor: 3.250

Review 9.  Bronchoalveolar lavage.

Authors:  H Y Reynolds
Journal:  Am Rev Respir Dis       Date:  1987-01

10.  Fibronectin in human bronchopulmonary lavage fluid. Elevation in patients with interstitial lung disease.

Authors:  S I Rennard; R G Crystal
Journal:  J Clin Invest       Date:  1982-01       Impact factor: 14.808

View more
  13 in total

1.  Elevated levels of matrix metalloproteinases in bronchoalveolar lavage fluid of emphysematous patients.

Authors:  G A Finlay; K J Russell; K J McMahon; E M D'arcy; J B Masterson; M X FitzGerald; C M O'Connor
Journal:  Thorax       Date:  1997-06       Impact factor: 9.139

Review 2.  Matrix metalloproteases and lung disease.

Authors:  C M O'Connor; M X FitzGerald
Journal:  Thorax       Date:  1994-06       Impact factor: 9.139

3.  Bronchoalveolar lavage in patients with mild and severe rheumatoid lung disease.

Authors:  D M Gilligan; C M O'Connor; K Ward; D Moloney; B Bresnihan; M X FitzGerald
Journal:  Thorax       Date:  1990-08       Impact factor: 9.139

Review 4.  Matrix metalloproteinases in destructive pulmonary pathology.

Authors:  P T G Elkington; J S Friedland
Journal:  Thorax       Date:  2005-10-14       Impact factor: 9.139

5.  Signs of alveolar inflammation in non-smoking Swedish wood trimmers.

Authors:  U Johard; A Eklund; M Dahlqvist; A Ahlander; R Alexandersson; U Ekholm; G Tornling; U Ulfvarsson
Journal:  Br J Ind Med       Date:  1992-06

6.  Alveolar macrophages from bronchoalveolar lavage of patients with pulmonary histiocytosis X: determination of phenotypic and functional changes.

Authors:  M Uebelhoer; B Bewig; K Sternberg; K Rabe; D Nowak; H Magnussen; J Barth
Journal:  Lung       Date:  1995       Impact factor: 2.584

Review 7.  New perspectives on basic mechanisms in lung disease. 6. Proteinase imbalance: its role in lung disease.

Authors:  T D Tetley
Journal:  Thorax       Date:  1993-05       Impact factor: 9.139

8.  Protein levels of CC chemokine ligand (CCL)15, CCL16 and macrophage stimulating protein in patients with sarcoidosis.

Authors:  A Arakelyan; E Kriegova; Z Kubistova; F Mrazek; M Kverka; R M du Bois; V Kolek; M Petrek
Journal:  Clin Exp Immunol       Date:  2009-03       Impact factor: 4.330

Review 9.  Pulmonary fibrosis: pathogenesis, etiology and regulation.

Authors:  M S Wilson; T A Wynn
Journal:  Mucosal Immunol       Date:  2009-01-07       Impact factor: 7.313

10.  Comparison between lung parenchyma and bronchoalveolar lavage collagenolytic activity.

Authors:  M Montaño; C Ramos; A Pardo; M Selman
Journal:  Lung       Date:  1993       Impact factor: 2.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.